巴曲酶治疗急性缺血性脑卒中的疗效观察  

作　　者：袁栋才[1] 郗红艳[1] 郭华[1] 闫海燕[1] 

机构地区：[1]河北省衡水哈励逊国际和平医院神经内科,053000

出　　处：《中国医药指南（学术版）》2008年第7期33-35,共3页Guide of China Medicine

摘　　要：目的探讨巴曲酶对急性缺血性脑卒中的治疗效果及时间的影响。方法选取60例发病在72h内的缺血性脑卒中患者,随机分为治疗组和对照组,治疗14d,观察血浆纤维蛋白的变化,评定治疗效果。结果早期应用巴曲酶能降低血浆纤维蛋白水平,提高治疗效果。结论巴曲酶治疗急性缺血性脑卒中,安全有效,无明显副作用。Objective To approach the effect of the therapeutic efficacy and time of batroxobin with acute ischemic stroke. Methods To select 60 patients who have acute ischemic stoke within 72 hours of onset, and these patients were divided into the treatment group and the control group randomly. To observe the change of fibrin and evaluate the curative effect by using the treatment of batroxobin after 14 days. Results It was very effective to decrease the blood plasm level of fibrin and improve the therapeutic efficacy by using batroxobin treatment in the earlier period. Conclusion It was safe and efficient to treat acute iechemlc stroke by using batroxobin without apparent side effect.

关 键 词：急性缺血性脑卒中 巴曲酶 治疗时间 疗效 

分 类 号：R743.3[医药卫生—神经病学与精神病学]